OPKO Health Shares Outstanding 2010-2025 | OPK

OPKO Health shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
OPKO Health Annual Shares Outstanding
(Millions of Shares)
2024 694
2023 752
2022 719
2021 648
2020 641
2019 595
2018 563
2017 559
2016 556
2015 488
2014 422
2013 355
2012 296
2011 281
2010 255
2009 233
OPKO Health Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 672
2024-12-31 694
2024-09-30 998
2024-06-30 697
2024-03-31 707
2023-12-31 752
2023-09-30 752
2023-06-30 752
2023-03-31 752
2022-12-31 719
2022-09-30 750
2022-06-30 713
2022-03-31 660
2021-12-31 648
2021-09-30 652
2021-06-30 647
2021-03-31 641
2020-12-31 641
2020-09-30 641
2020-06-30 641
2020-03-31 641
2019-12-31 595
2019-09-30 586
2019-06-30 586
2019-03-31 586
2018-12-31 563
2018-09-30 560
2018-06-30 560
2018-03-31 559
2017-12-31 559
2017-09-30 559
2017-06-30 564
2017-03-31 558
2016-12-31 556
2016-09-30 552
2016-06-30 557
2016-03-31 546
2015-12-31 488
2015-09-30 516
2015-06-30 462
2015-03-31 446
2014-12-31 422
2014-09-30 428
2014-06-30 413
2014-03-31 413
2013-12-31 355
2013-09-30 361
2013-06-30 337
2013-03-31 313
2012-12-31 296
2012-09-30 298
2012-06-30 298
2012-03-31 298
2011-12-31 281
2011-09-30 286
2011-06-30 285
2011-03-31 261
2010-12-31 255
2010-09-30 255
2010-06-30 255
2010-03-31 254
2009-12-31 233
2009-09-30 253
2009-06-30 226
2009-03-31 200
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.067B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $199.979B 87.59
Thermo Fisher Scientific (TMO) United States $152.379B 18.43
Edwards Lifesciences (EW) United States $45.667B 29.94
Alcon (ALC) Switzerland $42.389B 28.65
IDEXX Laboratories (IDXX) United States $42.210B 48.51
DexCom (DXCM) United States $33.568B 51.88
IQVIA Holdings (IQV) United States $25.587B 14.33
Mettler-Toledo (MTD) United States $24.309B 28.91
STERIS (STE) Ireland $23.816B 26.23
Waters (WAT) United States $21.016B 29.65
SONOVA HOLDING (SONVY) Switzerland $18.484B 0.00
Hologic (HOLX) United States $13.943B 15.15
Sysmex ADR (SSMXY) Japan $10.323B 29.29
Penumbra (PEN) United States $9.888B 77.61
Masimo (MASI) United States $8.836B 32.59
Globus Medical (GMED) United States $8.077B 19.25
Teleflex (TFX) United States $5.424B 8.95
Glaukos (GKOS) United States $5.198B 0.00
TransMedics (TMDX) United States $4.391B 95.45
Integer Holdings (ITGR) United States $4.193B 21.97
PROCEPT BioRobotics (PRCT) United States $3.410B 0.00
LivaNova (LIVN) United Kingdom $2.425B 14.44
Nihon Kohden (NHNKY) Japan $2.244B 25.74
Veracyte (VCYT) United States $2.137B 29.99
Elekta AB (EKTAY) Sweden $1.968B 17.69
Alphatec Holdings (ATEC) United States $1.795B 0.00
Tandem Diabetes Care (TNDM) United States $1.344B 0.00
Artivion (AORT) United States $1.224B 114.64
Pulse Biosciences (PLSE) United States $1.181B 0.00
Integra LifeSciences Holdings (IART) United States $1.018B 5.41
Beta Bionics (BBNX) United States $0.843B 0.00
SiBone (SIBN) United States $0.788B 0.00
IRadimed (IRMD) United States $0.773B 39.21
RxSight (RXST) United States $0.620B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.577B 8.97
Delcath Systems (DCTH) United States $0.570B 0.00
Mesa Laboratories (MLAB) United States $0.551B 12.91
AxoGen (AXGN) United States $0.496B 0.00
OrthoPediatrics (KIDS) United States $0.489B 0.00
AngioDynamics (ANGO) United States $0.445B 0.00
NeuroPace (NPCE) United States $0.432B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.427B 0.00
Semler Scientific (SMLR) United States $0.399B 10.61
ClearPoint Neuro (CLPT) United States $0.364B 0.00
Treace Medical Concepts (TMCI) United States $0.363B 0.00
Pacific Biosciences Of California (PACB) United States $0.309B 0.00
Neuronetics (STIM) United States $0.255B 0.00
908 Devices (MASS) United States $0.247B 0.00
Tactile Systems Technology (TCMD) United States $0.236B 14.28
Sight Sciences (SGHT) United States $0.219B 0.00
Alpha Tau Medical (DRTS) Israel $0.207B 0.00
CVRx (CVRX) United States $0.174B 0.00
Inogen (INGN) United States $0.173B 0.00
Anteris Technologies Global (AVR) Australia $0.171B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
Accuray (ARAY) United States $0.164B 0.00
LENSAR (LNSR) United States $0.159B 0.00
Biosig Technologies (BSGM) United States $0.157B 0.00
Rapid Micro Biosystems (RPID) United States $0.156B 0.00
Lucid Diagnostics (LUCD) United States $0.132B 0.00
Atossa Genetics (ATOS) United States $0.111B 0.00
Microbot Medical (MBOT) United States $0.100B 0.00
Monogram Orthopaedics (MGRM) United States $0.087B 0.00
Sensus Healthcare (SRTS) United States $0.080B 48.90
InspireMD (NSPR) United States $0.080B 0.00
EDAP TMS S.A (EDAP) France $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.065B 0.00
Hyperfine (HYPR) United States $0.055B 0.00
Positron (POSC) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.049B 0.00
Spectral AI (MDAI) United States $0.044B 0.00
Precision Optics (POCI) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
Baird Medical Investment Holdings (BDMD) $0.030B 0.00
Adagio Medical Holdings (ADGM) United States $0.018B 0.00
NexGel (NXGL) United States $0.018B 0.00
WORK Medical Technology Group (WOK) China $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.12
Longview Acquisition II (LGV) United States $0.000B 0.00